Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

BACKGROUND: The current standard treatment, at least in Europe, for patients with primarily resectable tumors, consists of surgery followed by adjuvant chemotherapy. But even in this prognostic favourable group, long term survival is disappointing because of high local and distant failure rates. Pos...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Roeder, Falk, Timke, Carmen, Saleh-Ebrahimi, Ladan, Schneider, Lutz, Hackert, Thilo, Hartwig, Werner, Kopp-Schneider, Annette, Hensley, Frank W, Buechler, Markus W, Debus, Juergen, Huber, Peter E, Werner, Jens
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2012
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3323416/
https://ncbi.nlm.nih.gov/pubmed/22443802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-112
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia